In view of the changing media landscape, Disney (NYSE:DIS) is an example of both a company beholden to its past, while also striving for the future. The multimedia powerhouse found itself in danger of becoming less relevant as declining subscriber rates and cord-cutting ate into Disney’s most profitable business: its media networks, including sports network ESPN. At least part of the blame can be attributed to the advent of streaming, as services like Netflix (NASDAQ:NFLX) offered an all-you-can-watch alternative at a much lower price point, causing viewers to dump cable packages.
Disney belatedly entered the streaming market, releasing an offering for sports fans: ESPN+. While this initial over-the-top service is a companion to its flagship sports network, it also acted as an important test of the company’s ability to attract subscribers in an increasingly crowded streaming market.
Its early results seem to bode well for Disney’s debut effort.
ESPN is a hit with customers. Image source: Disney.
Top 5 Stocks To Buy Right Now: Alcatel Lucent(ALU)
Advisors’ Opinion:
- [By Joseph Griffin]
Press coverage about Alcatel Lucent (NYSE:ALU) has been trending positive on Monday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Alcatel Lucent earned a news sentiment score of 0.27 on Accern’s scale. Accern also assigned headlines about the communications equipment provider an impact score of 48.5554072096128 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
- [By Ethan Ryder]
Media coverage about Alcatel Lucent (NYSE:ALU) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Alcatel Lucent earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave headlines about the communications equipment provider an impact score of 45.9413628150958 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Top 5 Stocks To Buy Right Now: Potash Corporation of Saskatchewan Inc.(POT)
Advisors’ Opinion:
- [By Joseph Griffin]
PotCoin (CURRENCY:POT) traded 0.6% higher against the US dollar during the 24 hour period ending at 23:00 PM E.T. on May 12th. PotCoin has a total market capitalization of $23.95 million and approximately $62,522.00 worth of PotCoin was traded on exchanges in the last 24 hours. During the last seven days, PotCoin has traded 17.8% lower against the US dollar. One PotCoin coin can now be purchased for approximately $0.11 or 0.00001293 BTC on popular cryptocurrency exchanges including Cryptopia, CoinExchange, Trade By Trade and Tux Exchange.
- [By Shane Hupp]
Media stories about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended somewhat positive recently, Accern reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Potash Co. of Saskatchewan earned a daily sentiment score of 0.23 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.852138495875 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
- [By Max Byerly]
PotCoin (CURRENCY:POT) traded 4% lower against the U.S. dollar during the 24-hour period ending at 0:00 AM Eastern on June 4th. PotCoin has a total market capitalization of $18.72 million and approximately $73,221.00 worth of PotCoin was traded on exchanges in the last 24 hours. In the last seven days, PotCoin has traded up 2.6% against the U.S. dollar. One PotCoin coin can now be purchased for approximately $0.0850 or 0.00001147 BTC on exchanges including CoinExchange, Tux Exchange, Trade By Trade and Bleutrade.
- [By Ethan Ryder]
Headlines about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Potash Co. of Saskatchewan earned a news impact score of 0.43 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.4285202328488 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Top 5 Stocks To Buy Right Now: Jack Henry & Associates Inc.(JKHY)
Advisors’ Opinion:
- [By Ethan Ryder]
Stifel Financial Corp increased its position in Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 12.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,616 shares of the technology company’s stock after acquiring an additional 6,990 shares during the period. Stifel Financial Corp’s holdings in Jack Henry & Associates were worth $7,436,000 as of its most recent SEC filing.
- [By Joseph Griffin]
Royce & Associates LP lessened its holdings in shares of Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 5.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 408,799 shares of the technology company’s stock after selling 21,500 shares during the quarter. Royce & Associates LP owned approximately 0.53% of Jack Henry & Associates worth $53,291,000 at the end of the most recent quarter.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Jack Henry & Associates (JKHY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribers]
Jack Henry & Associates Inc (NASDAQ:JKHY)Q4 2018 Earnings Conference CallAug. 22, 2018, 8:45 a.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Jack Henry & Associates (JKHY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Victory Capital Management Inc. lifted its stake in Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 12.9% during the first quarter, HoldingsChannel reports. The firm owned 37,261 shares of the technology company’s stock after purchasing an additional 4,244 shares during the quarter. Victory Capital Management Inc.’s holdings in Jack Henry & Associates were worth $4,507,000 as of its most recent SEC filing.
Top 5 Stocks To Buy Right Now: Impax Laboratories, Inc.(IPXL)
Advisors’ Opinion:
- [By Max Byerly]
News articles about Impax Laboratories (NASDAQ:IPXL) have trended somewhat positive on Sunday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Impax Laboratories earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the specialty pharmaceutical company an impact score of 43.4189030940397 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Top 5 Stocks To Buy Right Now: (SMPQY)
Advisors’ Opinion:
- [By ]
I studied the management running the company and found fantastic professionals coming from large institutions like Novartis AG (NYSE:NVS), Sun Pharmaceuticals Industries (OTCPK:SMPQY), AstraZeneca Group plc (NYSE:AZN), or Endo International plc (NASDAQ